Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Plasma Fractionation Companies

Plasma fractionation companies are instrumental in the production of therapeutic plasma-derived products. Through sophisticated processes, they fractionate plasma into its individual components, isolating valuable proteins such as immunoglobulins, clotting factors, and albumin. These companies provide critical supplies for treating a variety of medical conditions, including immune deficiencies, hemophilia, and neurological disorders. Their commitment to quality and safety ensures the availability of life-saving therapies derived from plasma.

Plasma Fractionation Key Companies

Latest Plasma Fractionation Companies Update

CSL Behring (Australia)Received FDA approval for the 50mL/10gm prefilled syringe for Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid) for patients with PI and CIPD.Partnered with research institutions to develop novel plasma-derived therapies for unmet medical needs.

Grifols (Spain)Launched their XEMBIFY, a 20% subcutaneous immunoglobulin (SCIG) approved for various primary immunodeficiency diseases in Europe.Focused on expanding their footprint in the growing SCIG market with convenient and patient-preferred delivery options.

Takeda Pharmaceutical (Japan) Collaborated with BPL (UK) to establish a joint venture plasma fractionation facility in India, expanding their global plasma collection and manufacturing capabilities.Focused on developing next-generation plasma-derived medicines with enhanced efficacy and targeted therapeutic applications.

Baxter International Received CE Mark approval for their VIGEVWO™ (immunoglobulin, human-normal, liquid), offering broad-spectrum antibody protection for immune-compromised individuals.Partnered with healthcare providers to improve access to plasma-derived therapies for patients in underserved regions.

Octapharma Signed a strategic partnership with Kedrion (Italy) for collaborative research and development of new plasma-derived medicines, further advancing the field.Emphasized their commitment to sustainable plasma collection practices and environmental responsibility.

List of Plasma Fractionation companies in the market

CSL Behring (US)

Grifols Therapeutics (Spain)

Baxter International Inc (US)

Mitsubishi Tanabe (Japan)

Takeda Pharmaceutical (Japan)

Octapharma AG (Switzerland)

Hualan Bio (China)

Kedrion S.p.A (Italy)

LFB group (France)

Biotest AG (Germany)

Plasma Fractionation Market Highlights:

Plasma Fractionation Market Size

Plasma Fractionation Market Trends

Plasma Fractionation Market Analysis

Plasma Fractionation Market Share

Plasma Fractionation Market Highlights:

Plasma Fractionation Market Trends

Plasma Fractionation Market Analysis

Plasma Fractionation Market Share

Plasma Fractionation Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.